Mitral Regurgitation - Valvular Heart Disease Guidelines

Valvular Heart Disease

ACC/AHA Valvular Heart Disease - Mitral Regurgitation GUIDELINES Apps brought to you charge courtesy of Guideline Central and Abbott Vascular.

Issue link: https://eguideline.guidelinecentral.com/i/362036

Contents of this Issue

Navigation

Page 16 of 59

Figure 2. Indications for AVR for Chronic AR AR Severe AR (stages C and D) • Vena contracta >0.6 cm • Holodiastolic aortic flow reversal • RVol ≥60 mL/beat • RF ≥50% • ERO ≥0.3 cm 2 • LV dilation Progressive AR (stage B) • Vena contracta ≤0.6 cm • RVol <60 mL/beat • RF <50% • ERO <0.3 cm 2 Symptomatic (stage D) Asymptomatic (stage C) Other cardiac surgery LVEF <50% (stage D) Other cardiac surgery LVEF ≥50% LVESD >50 mm (stage C2) LVEF ≥50% LVEDD >65 mm Low surgical risk LVEF ≥50% LVESD ≤50 mm LVEDD ≤65 mm AVR (IIb) AVR (IIa) AVR (I) Periodic Monitoring AVR (IIa) NO YES 15

Articles in this issue

view archives of Mitral Regurgitation - Valvular Heart Disease Guidelines - Valvular Heart Disease